3. Finally, we were not entirely clear on the EC’s position on the matter of liability protection and
compensation mechanisms. We would welcome a follow-up discussion on this topic with the
appropriate representatives of the EC, to take you through our concerns and the suggested way
forward to address this challenge. We are determined to making our vaccine available to the
world in an expedited manner at a not for profit basis during the pandemic period and a
resolution of this topic will be essential for us to move forward.
May I kindly ask that you confirm our correct understanding of the APA mechanism above and let us
know at your earliest convenience when we could plan a call between legal experts.
Kind regards,